Partnering Opportunities
This section is available to companies who would like to promote their intellectual property opportunities to the NW biotechnology community.
Current partnering opportunities:
Company Name: Not to be disclosed
Website: Not to disclosed
Contact Name: Robert Muir
Contact Phone: 01664 501 501
Contact Email: robert.muir@pera.com
Description of company activity:
Technology Area: In-vitro/vivo pharmacology, drug metabolism and pharmacokinetics, pharmaceutics, analytical chemistry, toxicology, clinical research.
Target Markets: Late pre-clinical to clinical development of cancer therapeutics in particular, gastric or oesophageal cancer.
The company is focusing their pharmaceutical R&D in generating new technologies for treating cancer, autoimmune and inflammatory diseases. They state that they have extensive experience in late stage pre-clinical and in early stage clinical development. In-house technology and know-how have been gained in both in-vitro & in-vivo pharmacology, drug metabolism and pharmacokinetics, pharmaceutics, analytical chemistry, toxicology, clinical research and regulatory affairs.
Partnering Opportunity sought:
Joint Venture, Technology Licensing or R&D No size requirements. Organisations who have well described projects with adequate IP protection, Proof of concept data and a defined mode of action. Preferably in late pre-clinical to clinical phase.
Expiry Date: 28/04/06
Please click here to add your Company's Partnering Opportunities
